Website Search
ID 15954

What is Leukemia?

BCL-2 is associated with the development of certain forms of leukemia that affect B-cells. If the gene is swapped onto a different chromosome, its protein is over-produced, resulting in B cells that do not function or self-destruct as they should.
chromosome 18,b cells,forms of leukemia,self destruct,leukemia,protein
Creative Commons License This work by Cold Spring Harbor Laboratory is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License.

Related content:

15413. Chromosome 18: BCL2 oncogene, Matt Ridley
Matt Ridley talks about chromosome 18, BCL2 oncogene.
15706. Philadelphia chromosome
A mutation that gives rise to the Philadelphia chromosome gives rise to leukemia.
15994. The chronic myeloid leukemia (CML) mutation
View the animation to learn about the Philadelphia chromosome, the abnormal chromosome that causes chronic myeloid leukemia.
15525. How Gleevec works to alleviate symptoms of myeloid leukemia, 3D animation with basic narration
View the animation to find out how the drug Gleevec™ inhibits the molecular cause of chronic myeloid leukemia.
15055. Using DNA science to control CML, Brian Druker
Brian Druker talks about how the drug he designed targets the molecular cause of CML.
1013. Diagnosis, Targeted therapies: Targeting activators, Sawyer 1
Professor Charles Sawyer explains that CML stands for chronic myeloid leukemia, which is a blood cancer and it is different from many cancers because it starts very slowly and patients when they're first diagnosed don't have many symptoms.
1012. Diagnosis, Targeted therapies: Targeting activators
In this section learn that tyrosine kinases are a family of activator proteins that trigger the cell signaling process leading to cell growth and division.
1010. Diagnosis, Targeted therapies
Conventional cancer drugs are cellular poisons that block replication or some other aspect of cell growth. These drugs affect all cells – healthy or cancerous.
15714. Brian Druker
Brian Druker is a professor at Oregon Health Sciences University.
15712. Bud and Yvonne
Bud and Yvonne are delighted by Bud's recovery thanks to Gleevec
Cold Spring Harbor Laboratory
CSHL HomeAbout CSHLResearchEducationPublic EventsNewsstandPartner With UsGiving